Clinical Chemistry, Malmö
1 – 10 of 1366
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Molecular signatures of oocyte viability identified by follicular fluid proteomics
- Contribution to journal › Article
-
Mark
Childhood cancer survivors with premature ovarian insufficiency have low bone mineral density at long term follow-up
(2026) In Bone
- Contribution to journal › Article
-
Mark
Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival
- Contribution to journal › Article
-
Mark
Shiga toxin delivery in extracellular vesicles induces high mortality and severe kidney injury in a Gb3-dependent manner
- Contribution to journal › Article
-
Mark
Evaluation of the 4Kscore in EPIC : Letter
(2026) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 35(7). p.1221-1221
- Contribution to journal › Article
-
Mark
Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors
- Contribution to journal › Article
-
Mark
Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness
- Contribution to journal › Article
-
Mark
Evaluation of a Particle Enhanced Turbidimetric Immunoassay (PETIA) for detecting calprotectin in sputum samples
- Contribution to journal › Article
